title: Effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutide.
authors.affiliation: Profil Institut für Stoffwechselforschung GmbH, Hellersbergstrasse 9, D-41460 Neuss, Germany. christoph.kapitza@profil.com
authors.forename: Christoph
authors.initials: C
authors.lastname: Kapitza
authors.forename: Milan
authors.initials: M
authors.lastname: Zdravkovic
authors.forename: Eric
authors.initials: E
authors.lastname: Zijlstra
authors.forename: Stine
authors.initials: S
authors.lastname: Segel
authors.forename: Tim
authors.initials: T
authors.lastname: Heise
authors.forename: Anne
authors.initials: A
authors.lastname: Flint
mesh_terms: D000328:Adult; D019540:Area Under Curve; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D007279:Injections, Subcutaneous / Q000009:adverse effects / Q000706:statistics & numerical data*; D000069450:Liraglutide; D008297:Male; D008875:Middle Aged
chemical_list: D007004:Hypoglycemic Agents; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1